Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.77 USD | -2.90% | -8.75% | +135.47% |
Apr. 11 | Oppenheimer Initiates Coverage on Q32 Bio With Outperform Rating, $50 Price Target | MT |
Apr. 03 | Q32 Bio Inc. Appoints Lee Kalowski as Chief Financial Officer | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+135.47% | 307M | |
-1.65% | 103B | |
+6.75% | 101B | |
+6.40% | 23.07B | |
-12.60% | 22.23B | |
-6.31% | 18.05B | |
-39.98% | 17.18B | |
-10.17% | 16.94B | |
+6.12% | 14.07B | |
+35.47% | 12.35B |
- Stock Market
- Equities
- QTTB Stock
- News Q32 Bio Inc.
- Chardan Lowers Price Target on Homology Medicines to $8 From $10, Keeps Buy Rating